Comparative in vitro activity of levofloxacin and ciprofloxacin against bacterial isolates from neutropenic patients

Chemotherapy

Volumn 48, Issue 3, 2002, Pages 134-137

  Di Bonaventura, G ^a   D'antonio, D ^b   Catamo, G ^a   D'ercole, S ^a   Piccolomini, R ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Ciprofloxacin; E test; Fluoroquinolones; Levofloxacin; Neutropenic patients

Indexed keywords

CIPROFLOXACIN; LEVOFLOXACIN; ANTIINFECTIVE AGENT; OFLOXACIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; GRAM NEGATIVE BACTERIUM; HUMAN; IN VITRO STUDY; NEUTROPENIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; COMPARATIVE STUDY; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOGENICITY;

ANTI-INFECTIVE AGENTS, FLUOROQUINOLONE; CIPROFLOXACIN; COMPARATIVE STUDY; HUMAN; MICROBIAL SENSITIVITY TESTS; NEUTROPENIA; OFLOXACIN; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; SUPPORT, NON-U.S. GOV'T; ANTI-INFECTIVE AGENTS; HUMANS;

EID: 0035986273     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000064918     Document Type: Article

References (24)

1. Science and pragmatism in the treatment and prevention of neutropenic infection
2. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients
3. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies
4. The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora
5. The prophylaxis of bacterial infections in neutropenic patients
6. In vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacin
7. In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacin
8. Levofloxacin in vitro activity: Results from an international comparative study with ofloxacin and ciprofloxacin
9. In vitro activity of levofloxacin against gram-positive bacteria
10. In vitro activity of ofloxacin, levofloxacin, and D-ofloxacin against staphylococci
11. In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections
12. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin
13. Critical appaisal of E test for the detection of fluoroquinolone resistance
14. The changing pattern of infection in neutropenic patients
15. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones
16. In-vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer
17. Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and haematology/oncology patients in Switzerland: A multicentre study
18. Bacteremia due to fluoroquinolone-resistant Escherichia coliin two immunocompromised patients
19. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia
20. Italian survey on comparative levofloxacin susceptibility in 334 clinical isolates of Pseudomonas aeruginosa
21. Comparative in vitro activity of levofloxacin against isolates of bacteria from adult patients with community-acquired lower respiratory tract infections
22. In-vitro antibacterial activity of levofloxacin against hospital isolates: A multicentre study
23. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria